Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas B Brunner

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Cancer Biology & Therapy|July 25, 2012
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapyRemko Prevo, Emmanouil Fokas, Philip M Reaper, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 25, 2020
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitroA Allam Mohamed, Andreas Thomsen, Marie Follo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancerThomas B Brunner, Matthias Geiger, Gerhard G Grabenbauer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2020
ESTRO ACROP guidelines for target volume definition in pancreatic cancerThomas B Brunner, Karin Haustermans, Florence Huguet, et al.
Cancers|March 25, 2022
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II StudyEleni Gkika, Anca-Ligia Grosu, Teresa Macarulla Mercade, et al.
Neoplasia (New York, N.Y.)|April 27, 2007
Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cellsKeith A Cengel, K Rahn Voong, Sanjay Chandrasekaran, et al.
Gastroenterology|July 6, 2004
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogeneFranz S Schreiber, Therese B Deramaudt, Thomas B Brunner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 17, 2019
ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgeryLotte Wilke, Nicolaus Andratschke, Oliver Blanck, et al.
Brachytherapy|September 17, 2019
Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignanciesPeter Hass, Konrad Mohnike, Siegfried Kropf, et al.
Frontiers in Oncology|October 18, 2024
The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studiesEleni Gkika, Gianluca Radicioni, Alexandra Eichhorst, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Cancer Biology & Therapy|July 25, 2012
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapyRemko Prevo, Emmanouil Fokas, Philip M Reaper, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 25, 2020
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitroA Allam Mohamed, Andreas Thomsen, Marie Follo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancerThomas B Brunner, Matthias Geiger, Gerhard G Grabenbauer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2020
ESTRO ACROP guidelines for target volume definition in pancreatic cancerThomas B Brunner, Karin Haustermans, Florence Huguet, et al.
Cancers|March 25, 2022
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II StudyEleni Gkika, Anca-Ligia Grosu, Teresa Macarulla Mercade, et al.
Neoplasia (New York, N.Y.)|April 27, 2007
Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cellsKeith A Cengel, K Rahn Voong, Sanjay Chandrasekaran, et al.
Gastroenterology|July 6, 2004
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogeneFranz S Schreiber, Therese B Deramaudt, Thomas B Brunner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 17, 2019
ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgeryLotte Wilke, Nicolaus Andratschke, Oliver Blanck, et al.
Brachytherapy|September 17, 2019
Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignanciesPeter Hass, Konrad Mohnike, Siegfried Kropf, et al.
Frontiers in Oncology|October 18, 2024
The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studiesEleni Gkika, Gianluca Radicioni, Alexandra Eichhorst, et al.
Pageof 10